|
|
Intrapartum Oxytocin (Mis)use in South Asia
|
|
|
|
Oxytocin is a natural hormone with uterine stimulant properties that
plays a prominent role in obstetric practice. Clinical guidelines for oxytocin use
intrapartum emphasise that injudicious use has serious potential for adverse
outcomes for mother and baby. Oxytocin is readily available in South Asia and
widely used in ways that flout these guidelines. Yet recommendations for active
management of third stage of labour (AMTSL) include the administration of
oxytocin to prevent post-partum haemorrhage (PPH). Troublingly, these proposals
seem to ignore oxytocin’s already extensive life independent of policy interventions.
Taking oxytocin as an example, the paper argues that policy-makers urgently
need to engage with the everyday realities of drug availability and use in the
South Asia.
|
|
|
by Petra Brhlikova, Patricia Jeffery, Gitanjali Priti Bhatia, Sakshi Khurana | Vol.2, No.1,2,3, -2009-Tracing Pharmaceuticals in South Asia: Drugs, Doctors and Public Policy
|
View
Download
|
|
|
|
|
|
|
|
|